Log In
BCIQ
Print this Print this
 

CD20

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting CD20

BCIQ
Print ChartPrint this
0 0 0 0 0 0 0 0 1 2 10 10 7 2 8 1 1 6 2 3 3 2 4 5 0 0 1
Phases of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase IIIRegistrationApprovedMarketed
Autoimmune

2

3

3

2

4

5

0

0

1

Cancer

2

10

10

7

2

8

1

1

6

Inflammation

0

0

0

0

0

0

0

0

1




 Products Targeting CD20
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

17

$16,666.2M

$14,699.3M

$1,938.7M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today